Dysregulated HDL metabolism has also been linked to brain disorders: a decrease in plasma levels of HDL-c and/or apoA-I are risk factors for memory decline and neurodegenerative diseases, such as Alzheimer’s disease (AD) (Vitali et al., 2014). Here, APOA1 is linked to early-onset autosomal dominant Alzheimer disease.